Medlive Technology Co., Ltd. (HKG:2192)
Hong Kong · Delayed Price · Currency is HKD 6.43
-0.31 (-4.60%)
Oct 2, 2026, 4:08 PM HKT
Medlive Technology Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Medlive Technology stock has a consensus rating of "Strong Buy" and an average price target of $10.46. The average 1-year stock price forecast is 62.67% higher than the current stock price, while the lowest is $9.01 (+40.12%) and the highest is $11.55 (+79.63%).
Price Target: $10.46 (+62.67%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Medlive Technology stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 5 | 5 | 5 | 5 | 5 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Citic Securities No rating | Citic Securities | Buy Maintains $9.00 | Buy | Maintains | $9.00 | +39.97% | Sep 23, 2026 |
Unknown Analyst CICC No rating | CICC | Buy Maintains $10.50 | Buy | Maintains | $10.50 | +63.30% | Sep 2, 2026 |
Unknown Analyst HSBC No rating | HSBC | Buy Maintains $12.00 | Buy | Maintains | $12.00 | +86.63% | Jul 22, 2026 |
Financial Forecast
Revenue This Year
695.50M
from 642.16M
Increased by 8.31%
Revenue Next Year
793.27M
from 695.50M
Increased by 14.06%
EPS This Year
0.48
from 0.46
Increased by 4.22%
EPS Next Year
0.54
from 0.48
Increased by 11.16%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.